middle.news
Island Pharmaceuticals Taps BioCryst Veteran to Boost Galidesivir’s US Biodefence Push
9:25am on Thursday 21st of May, 2026 AEST
•
Healthcare
Read Story
Island Pharmaceuticals Taps BioCryst Veteran to Boost Galidesivir’s US Biodefence Push
9:25am on Thursday 21st of May, 2026 AEST
Key Points
Raymond Taylor brings 40+ years antiviral and biodefence expertise
Direct historical involvement with Galidesivir development
Experience managing over US$490m in US government biodefence funding
Strengthens Island’s FDA Animal Rule pathway execution
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE